Please use this identifier to cite or link to this item:
|Title:||Receptor activator of nuclear factor-kB ligand -RANKL- as a novel prognostic marker in prostate carcinoma|
|Publisher:||Murcia : F. Hernández|
|Related subjects:||616.6 - Patología del sistema genitourinario|
|Abstract:||Combined immunodetection of parathyroid hormone-related protein (PTHrP) and receptor activator of NF-kB ligand (RANKL) has shown to successfully distinguish poorly- and well-differentiated prostate carcinoma (PCa). In the present study, we aimed to assess whether immunohistochemical evaluation of these factors, and also osteoprotegerin (OPG) and Ki67, in radical prostatectomy specimens can predict biochemical recurrence. Fifty nine PCa cases undergoing radical prostatectomy between 1995 and 1998, without history of neoadjuvant hormonal therapy, were studied. Preoperative serum prostate-specific antigen (PSA), Gleason-sum score, pathologic stage, perineural invasion, seminal vesicle involvement, and positive surgical margins were assessed in these patients. Biochemical recurrence, defined by PSA > 0.4 ng/mL at 90 days or later after prostatectomy, occurred in 32/59 patients. In these patients, positivity for OPG and RANKL in the tumoral epithelium was higher than in those patients with no biochemical recurrence. Using univariate analysis, Gleason-sum score, surgical margins, and seminal vesicle involvement, as well as OPG and RANKL immunostaining (using a score value corresponding to moderate staining as cut-off) were significant predictors of biochemical recurrence (p<0.05). Using the multivariate Cox model, among the evaluated factors only RANKL expression (hazard ratio 11.6; p <0.001) was an independent prognostic indicator. Our findings suggest that immunohistochemical evaluation of RANKL in the primary tumor is a potential risk factor in PCa patients.|
|Primary author:||Pérez-Martínez, Francisco C.|
Sarasa, José L.
Calahorra, Francisco J.
|Published in:||Histology and histopathology|
|Number of pages / Extensions:||7|
|Appears in Collections:||Vol.23, nº6 (2008)|
Files in This Item:
|Receptor activator of nuclear factor-kB ligand -RANKL- as a novel prognostic marker in prostate carcinoma.pdf||1,49 MB||Adobe PDF||View/Open|
Items in Digitum are protected by copyright, with all rights reserved, unless otherwise indicated.